Natus Medical Financial Ratios

Natus Medical Incorporated -- USA Stock  

USD 29.05  0.4  1.4%

Use fundamental data analysis to check out all available financial ratios of Natus Medical Incorp to find out if markets are presently mispricing the entity. We found thirty-six available fundamentals for Natus Medical which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Natus Medical Incorporated fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that Natus Medical Incorp has Number of Shares Shorted of 3.49 M, we recommend you check Natus Medical last-minute market performance to make sure the company can sustain itself down the road.Use Natus Medical to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Natus Medical to be traded at $31.96 in 30 days

Natus Medical Incorp Valuation Over Time

Enterprise Value

Natus Medical Company Summary

Natus Medical competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. It offers solutions and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders neuromuscular diseases and balance and mobility disorders. Natus Medical Incs product offerings include computerized neurodiagnostic systems for audiology neurology polysomnography and neonatology and software systems for managing and tracking disorders and diseases for public health laboratories. It offers neurology products such as diagnostic electroencephalography and longterm monitoring products electrodiagnostic monitoring products diagnostic polysomnography monitoring products diagnostic intraoperative monitoring products and transcranial Doppler products. Natus Medical Inc also offer newborn care products including hearing screening solutions to screen the hearing brain injury solutions to diagnose the severity of brain injury monitor the effectiveness of drug therapies detect seizure activity and monitor general neurological status and thermoregulation solutions to control the newborn environment including incubators and warmers. Its newborn care also comprise jaundice management solutions to measure bilirubin levels and treat jaundice diagnostic hearing assessment solutions to screen for or diagnose hearing loss or to identify abnormalities affecting the peripheral and central auditory nervous systems in patients of all ages balance and mobility systems to diagnose and assist in treating balance disorders and NicView video for families with babies in the neonatal intensive care unit. Natus Medical Inc serves hospitals clinics laboratories physicians nurses audiologists and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in Pleasanton California.

Natus Medical Cash per Share vs Operating Margin

Natus Medical Incorporated is number one stock in cash per share category among related companies. It is number one stock in operating margin category among related companies reporting about  1.09  of Operating Margin per Cash per Share.

Natus Medical Incorp Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Natus Medical Incorp correlated with the market. If Beta is less then 0 Natus Medical generally moves in the opposite direction as compared to the market. If Natus Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Natus Medical Incorp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Natus Medical is generally in the same direction as the market. If Beta > 1 Natus Medical moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 28% 

Chance of Financial Distress

Natus Medical Incorporated has less than 28 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Natus Medical Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare Natus Medical To Peers
James Hawkins CEO and President and Director
Robert Gunst Independent Chairman of the Board
More Executives

Opportunity Range

January 23, 2018 Opportunity Range